Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Is FIB-4 the right tool for screening for liver fibrosis?
Leen JM. Heyens; Demi P.A.van Malde; Gediz Dogay Us; Francesco Innocenti; Mathieu Struyve; Christophe Van Steenkiste; Sven Francque; Geert Robaeys; Ger H. Koek;
10.1016/j.aohep.2025.102176
Validation of the Hepamet fibrosis score in a multi-ethnic Asian population
Shi-En Chong; Felicia Chang; Kee-Huat Chuah; Pavai Sthaneshwar; Nik Raihan Nik Mustapha; Sanjiv Mahadeva; Wah-Kheong Chan;
Ann Hepatol. 2023;28:
The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study
Osama Hamid; Ahmed Eltelbany; Abdul Mohammed; Khaled Alsabbagh Alchirazi; Sushrut Trakroo; Imad Asaad;
Ann Hepatol. 2022;27: